ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RSPI RespireRx Pharmaceuticals Inc (PK)

0.00087
0.00002 (2.35%)
Apr 25 2024 - Closed
Delayed by 15 minutes

RespireRx Pharmaceuticals (PK) Financial Summary

The current RSPI market cap is 317.91k. The company's latest EPS is USD -0.0109 and P/E is 0.00.

Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -2.18M-1.74M-3.32M-2.56M-1.58M
Net Income -2.59M-2.12M-5.74M-3.52M-3.97M
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 124k45k85k209k23k
Total Liabilities 5.86M7.49M8.15M10.22M11.9M
Total Equity -5.73M-7.45M-8.06M-10.01M-11.88M

Cash Flow

Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -428k-487k-513k-956k-144k
Investing N/A N/A N/A N/A N/A
Financing 376k471k497k956k143k
Market Cap 317.91k
Price to Earnings Ratio 0.00
Price to Sales Ratio 0
Price to Cash Ratio 0
Price to Book Ratio 0
Dividend Yield -

Share Statistics

Shares Outstanding 365.42M
Average Volume (1 week) 1.63M
Average Volume (1 Month) 3.48M
52 Week Change -68.93%
52 Week High 0.0191
52 Week Low 0.0006
Spread (Intraday) 0 (20%)

Company Info

Company Name RespireRx Pharmaceuticals Inc (PK)
Address 900 foulk road
wilmington, delaware 19803
Website https://www.respirerx.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock